Medical Care
Global Oncolytic Virus Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 16, 25
- ID: 189288
- Pages: 99
- Figures: 100
- Views: 37
The global Oncolytic Virus Therapy market size was US$ 9.3 million in 2024 and is forecast to a readjusted size of US$ 43.3 million by 2031 with a CAGR of 24.9% during the forecast period 2025-2031.
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.
The global Oncolytic Virus Therapy market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
By Type: (Dominant Segment vs High-Margin Innovation)
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
By Application: (Core Demand Driver vs Emerging Opportunity)
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Amgen in Europe)
- Emerging Product Trends: HSV-based Oncolytic Viruses adoption vs. Adenoviruses-based Oncolytic Viruses premiumization
- Demand-Side Dynamics: Melanoma growth in China vs. Prostate Cancer potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Asia Pacific
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Oncolytic Virus Therapy market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Adenoviruses-based Oncolytic Viruses in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Prostate Cancer in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Oncolytic Virus Therapy value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.
The global Oncolytic Virus Therapy market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
By Type: (Dominant Segment vs High-Margin Innovation)
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
By Application: (Core Demand Driver vs Emerging Opportunity)
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Amgen in Europe)
- Emerging Product Trends: HSV-based Oncolytic Viruses adoption vs. Adenoviruses-based Oncolytic Viruses premiumization
- Demand-Side Dynamics: Melanoma growth in China vs. Prostate Cancer potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Asia Pacific
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Oncolytic Virus Therapy market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Adenoviruses-based Oncolytic Viruses in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Prostate Cancer in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Oncolytic Virus Therapy value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 HSV-based Oncolytic Viruses
1.2.3 Adenoviruses-based Oncolytic Viruses
1.2.4 Vaccinia Virus-based Oncolytic Viruses
1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
1.2.6 Newcastle Disease Virus-based Oncolytic Viruses
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Melanoma
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Therapy Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Oncolytic Virus Therapy Revenue Market Share by Region (2020-2025)
2.4 Global Oncolytic Virus Therapy Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Oncolytic Virus Therapy Market Size and Prospective (2020-2031)
2.5.2 Europe Oncolytic Virus Therapy Market Size and Prospective (2020-2031)
2.5.3 Asia Pacific Oncolytic Virus Therapy Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Oncolytic Virus Therapy Historic Market Size by Type (2020-2025)
3.2 Global Oncolytic Virus Therapy Forecasted Market Size by Type (2026-2031)
3.3 Different Types Oncolytic Virus Therapy Representative Players
4 Breakdown Data by Application
4.1 Global Oncolytic Virus Therapy Historic Market Size by Application (2020-2025)
4.2 Global Oncolytic Virus Therapy Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Oncolytic Virus Therapy Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Oncolytic Virus Therapy Players by Revenue (2020-2025)
5.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Oncolytic Virus Therapy Revenue
5.4 Global Oncolytic Virus Therapy Market Concentration Analysis
5.4.1 Global Oncolytic Virus Therapy Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Therapy Revenue in 2024
5.5 Global Key Players of Oncolytic Virus Therapy Head office and Area Served
5.6 Global Key Players of Oncolytic Virus Therapy, Product and Application
5.7 Global Key Players of Oncolytic Virus Therapy, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Oncolytic Virus Therapy Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Oncolytic Virus Therapy Market Size by Type (2020-2025)
6.1.2.2 North America Oncolytic Virus Therapy Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Oncolytic Virus Therapy Market Size by Application (2020-2025)
6.1.3.2 North America Oncolytic Virus Therapy Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Oncolytic Virus Therapy Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Oncolytic Virus Therapy Market Size by Type (2020-2025)
6.2.2.2 Europe Oncolytic Virus Therapy Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Oncolytic Virus Therapy Market Size by Application (2020-2025)
6.2.3.2 Europe Oncolytic Virus Therapy Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia Pacific Market: Players, Segments and Downstream
6.3.1 Asia Pacific Oncolytic Virus Therapy Revenue by Company (2020-2025)
6.3.2 Asia Pacific Market Size by Type
6.3.2.1 Asia Pacific Oncolytic Virus Therapy Market Size by Type (2020-2025)
6.3.2.2 Asia Pacific Oncolytic Virus Therapy Market Share by Type (2020-2025)
6.3.3 Asia Pacific Market Size by Application
6.3.3.1 Asia Pacific Oncolytic Virus Therapy Market Size by Application (2020-2025)
6.3.3.2 Asia Pacific Oncolytic Virus Therapy Market Share by Application (2020-2025)
6.3.4 Asia Pacific Market Trend and Opportunities
7 Key Players Profiles
7.1 Amgen
7.1.1 Amgen Company Details
7.1.2 Amgen Business Overview
7.1.3 Amgen Oncolytic Virus Therapy Introduction
7.1.4 Amgen Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.1.5 Amgen Recent Development
7.2 Oncolytics Biotech
7.2.1 Oncolytics Biotech Company Details
7.2.2 Oncolytics Biotech Business Overview
7.2.3 Oncolytics Biotech Oncolytic Virus Therapy Introduction
7.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.2.5 Oncolytics Biotech Recent Development
7.3 Viralytics
7.3.1 Viralytics Company Details
7.3.2 Viralytics Business Overview
7.3.3 Viralytics Oncolytic Virus Therapy Introduction
7.3.4 Viralytics Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.3.5 Viralytics Recent Development
7.4 Transgene SA
7.4.1 Transgene SA Company Details
7.4.2 Transgene SA Business Overview
7.4.3 Transgene SA Oncolytic Virus Therapy Introduction
7.4.4 Transgene SA Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.4.5 Transgene SA Recent Development
7.5 Oncolys BioPharma
7.5.1 Oncolys BioPharma Company Details
7.5.2 Oncolys BioPharma Business Overview
7.5.3 Oncolys BioPharma Oncolytic Virus Therapy Introduction
7.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.5.5 Oncolys BioPharma Recent Development
7.6 Targovax
7.6.1 Targovax Company Details
7.6.2 Targovax Business Overview
7.6.3 Targovax Oncolytic Virus Therapy Introduction
7.6.4 Targovax Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.6.5 Targovax Recent Development
7.7 PsiOxus Therapeutics
7.7.1 PsiOxus Therapeutics Company Details
7.7.2 PsiOxus Therapeutics Business Overview
7.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Introduction
7.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.7.5 PsiOxus Therapeutics Recent Development
7.8 SillaJen Biotherapeutics
7.8.1 SillaJen Biotherapeutics Company Details
7.8.2 SillaJen Biotherapeutics Business Overview
7.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Introduction
7.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.8.5 SillaJen Biotherapeutics Recent Development
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Company Details
7.9.2 Sorrento Therapeutics Business Overview
7.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Introduction
7.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.9.5 Sorrento Therapeutics Recent Development
7.10 Lokon Pharma
7.10.1 Lokon Pharma Company Details
7.10.2 Lokon Pharma Business Overview
7.10.3 Lokon Pharma Oncolytic Virus Therapy Introduction
7.10.4 Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.10.5 Lokon Pharma Recent Development
7.11 Genelux Corporation
7.11.1 Genelux Corporation Company Details
7.11.2 Genelux Corporation Business Overview
7.11.3 Genelux Corporation Oncolytic Virus Therapy Introduction
7.11.4 Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.11.5 Genelux Corporation Recent Development
7.12 Vyriad
7.12.1 Vyriad Company Details
7.12.2 Vyriad Business Overview
7.12.3 Vyriad Oncolytic Virus Therapy Introduction
7.12.4 Vyriad Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.12.5 Vyriad Recent Development
7.13 TILT Biotherapeutics
7.13.1 TILT Biotherapeutics Company Details
7.13.2 TILT Biotherapeutics Business Overview
7.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Introduction
7.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.13.5 TILT Biotherapeutics Recent Development
7.14 Cold Genesys
7.14.1 Cold Genesys Company Details
7.14.2 Cold Genesys Business Overview
7.14.3 Cold Genesys Oncolytic Virus Therapy Introduction
7.14.4 Cold Genesys Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.14.5 Cold Genesys Recent Development
8 Oncolytic Virus Therapy Market Dynamics
8.1 Oncolytic Virus Therapy Industry Trends
8.2 Oncolytic Virus Therapy Market Drivers
8.3 Oncolytic Virus Therapy Market Challenges
8.4 Oncolytic Virus Therapy Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 HSV-based Oncolytic Viruses
1.2.3 Adenoviruses-based Oncolytic Viruses
1.2.4 Vaccinia Virus-based Oncolytic Viruses
1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
1.2.6 Newcastle Disease Virus-based Oncolytic Viruses
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Melanoma
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Therapy Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Oncolytic Virus Therapy Revenue Market Share by Region (2020-2025)
2.4 Global Oncolytic Virus Therapy Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Oncolytic Virus Therapy Market Size and Prospective (2020-2031)
2.5.2 Europe Oncolytic Virus Therapy Market Size and Prospective (2020-2031)
2.5.3 Asia Pacific Oncolytic Virus Therapy Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Oncolytic Virus Therapy Historic Market Size by Type (2020-2025)
3.2 Global Oncolytic Virus Therapy Forecasted Market Size by Type (2026-2031)
3.3 Different Types Oncolytic Virus Therapy Representative Players
4 Breakdown Data by Application
4.1 Global Oncolytic Virus Therapy Historic Market Size by Application (2020-2025)
4.2 Global Oncolytic Virus Therapy Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Oncolytic Virus Therapy Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Oncolytic Virus Therapy Players by Revenue (2020-2025)
5.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Oncolytic Virus Therapy Revenue
5.4 Global Oncolytic Virus Therapy Market Concentration Analysis
5.4.1 Global Oncolytic Virus Therapy Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Therapy Revenue in 2024
5.5 Global Key Players of Oncolytic Virus Therapy Head office and Area Served
5.6 Global Key Players of Oncolytic Virus Therapy, Product and Application
5.7 Global Key Players of Oncolytic Virus Therapy, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Oncolytic Virus Therapy Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Oncolytic Virus Therapy Market Size by Type (2020-2025)
6.1.2.2 North America Oncolytic Virus Therapy Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Oncolytic Virus Therapy Market Size by Application (2020-2025)
6.1.3.2 North America Oncolytic Virus Therapy Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Oncolytic Virus Therapy Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Oncolytic Virus Therapy Market Size by Type (2020-2025)
6.2.2.2 Europe Oncolytic Virus Therapy Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Oncolytic Virus Therapy Market Size by Application (2020-2025)
6.2.3.2 Europe Oncolytic Virus Therapy Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia Pacific Market: Players, Segments and Downstream
6.3.1 Asia Pacific Oncolytic Virus Therapy Revenue by Company (2020-2025)
6.3.2 Asia Pacific Market Size by Type
6.3.2.1 Asia Pacific Oncolytic Virus Therapy Market Size by Type (2020-2025)
6.3.2.2 Asia Pacific Oncolytic Virus Therapy Market Share by Type (2020-2025)
6.3.3 Asia Pacific Market Size by Application
6.3.3.1 Asia Pacific Oncolytic Virus Therapy Market Size by Application (2020-2025)
6.3.3.2 Asia Pacific Oncolytic Virus Therapy Market Share by Application (2020-2025)
6.3.4 Asia Pacific Market Trend and Opportunities
7 Key Players Profiles
7.1 Amgen
7.1.1 Amgen Company Details
7.1.2 Amgen Business Overview
7.1.3 Amgen Oncolytic Virus Therapy Introduction
7.1.4 Amgen Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.1.5 Amgen Recent Development
7.2 Oncolytics Biotech
7.2.1 Oncolytics Biotech Company Details
7.2.2 Oncolytics Biotech Business Overview
7.2.3 Oncolytics Biotech Oncolytic Virus Therapy Introduction
7.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.2.5 Oncolytics Biotech Recent Development
7.3 Viralytics
7.3.1 Viralytics Company Details
7.3.2 Viralytics Business Overview
7.3.3 Viralytics Oncolytic Virus Therapy Introduction
7.3.4 Viralytics Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.3.5 Viralytics Recent Development
7.4 Transgene SA
7.4.1 Transgene SA Company Details
7.4.2 Transgene SA Business Overview
7.4.3 Transgene SA Oncolytic Virus Therapy Introduction
7.4.4 Transgene SA Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.4.5 Transgene SA Recent Development
7.5 Oncolys BioPharma
7.5.1 Oncolys BioPharma Company Details
7.5.2 Oncolys BioPharma Business Overview
7.5.3 Oncolys BioPharma Oncolytic Virus Therapy Introduction
7.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.5.5 Oncolys BioPharma Recent Development
7.6 Targovax
7.6.1 Targovax Company Details
7.6.2 Targovax Business Overview
7.6.3 Targovax Oncolytic Virus Therapy Introduction
7.6.4 Targovax Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.6.5 Targovax Recent Development
7.7 PsiOxus Therapeutics
7.7.1 PsiOxus Therapeutics Company Details
7.7.2 PsiOxus Therapeutics Business Overview
7.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Introduction
7.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.7.5 PsiOxus Therapeutics Recent Development
7.8 SillaJen Biotherapeutics
7.8.1 SillaJen Biotherapeutics Company Details
7.8.2 SillaJen Biotherapeutics Business Overview
7.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Introduction
7.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.8.5 SillaJen Biotherapeutics Recent Development
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Company Details
7.9.2 Sorrento Therapeutics Business Overview
7.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Introduction
7.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.9.5 Sorrento Therapeutics Recent Development
7.10 Lokon Pharma
7.10.1 Lokon Pharma Company Details
7.10.2 Lokon Pharma Business Overview
7.10.3 Lokon Pharma Oncolytic Virus Therapy Introduction
7.10.4 Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.10.5 Lokon Pharma Recent Development
7.11 Genelux Corporation
7.11.1 Genelux Corporation Company Details
7.11.2 Genelux Corporation Business Overview
7.11.3 Genelux Corporation Oncolytic Virus Therapy Introduction
7.11.4 Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.11.5 Genelux Corporation Recent Development
7.12 Vyriad
7.12.1 Vyriad Company Details
7.12.2 Vyriad Business Overview
7.12.3 Vyriad Oncolytic Virus Therapy Introduction
7.12.4 Vyriad Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.12.5 Vyriad Recent Development
7.13 TILT Biotherapeutics
7.13.1 TILT Biotherapeutics Company Details
7.13.2 TILT Biotherapeutics Business Overview
7.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Introduction
7.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.13.5 TILT Biotherapeutics Recent Development
7.14 Cold Genesys
7.14.1 Cold Genesys Company Details
7.14.2 Cold Genesys Business Overview
7.14.3 Cold Genesys Oncolytic Virus Therapy Introduction
7.14.4 Cold Genesys Revenue in Oncolytic Virus Therapy Business (2020-2025)
7.14.5 Cold Genesys Recent Development
8 Oncolytic Virus Therapy Market Dynamics
8.1 Oncolytic Virus Therapy Industry Trends
8.2 Oncolytic Virus Therapy Market Drivers
8.3 Oncolytic Virus Therapy Market Challenges
8.4 Oncolytic Virus Therapy Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Oncolytic Virus Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Oncolytic Virus Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Oncolytic Virus Therapy Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Oncolytic Virus Therapy Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Oncolytic Virus Therapy Revenue Share by Region (2020-2025)
Table 6. Global Oncolytic Virus Therapy Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Oncolytic Virus Therapy Revenue Share Forecast by Region (2026-2031)
Table 8. Global Oncolytic Virus Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Oncolytic Virus Therapy Revenue Market Share by Type (2020-2025)
Table 10. Global Oncolytic Virus Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Oncolytic Virus Therapy Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Oncolytic Virus Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Oncolytic Virus Therapy Revenue Market Share by Application (2020-2025)
Table 15. Global Oncolytic Virus Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Oncolytic Virus Therapy Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Oncolytic Virus Therapy Application
Table 18. Global Oncolytic Virus Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Oncolytic Virus Therapy Market Share by Players (2020-2025)
Table 20. Global Top Oncolytic Virus Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2024)
Table 21. Ranking of Global Top Oncolytic Virus Therapy Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Oncolytic Virus Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Oncolytic Virus Therapy, Headquarters and Area Served
Table 24. Global Key Players of Oncolytic Virus Therapy, Product and Application
Table 25. Global Key Players of Oncolytic Virus Therapy, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Oncolytic Virus Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Oncolytic Virus Therapy Revenue Market Share by Company (2020-2025)
Table 29. North America Oncolytic Virus Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Oncolytic Virus Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Oncolytic Virus Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Oncolytic Virus Therapy Revenue Market Share by Company (2020-2025)
Table 33. Europe Oncolytic Virus Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Oncolytic Virus Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 35. Asia Pacific Oncolytic Virus Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 36. Asia Pacific Oncolytic Virus Therapy Revenue Market Share by Company (2020-2025)
Table 37. Asia Pacific Oncolytic Virus Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 38. Asia Pacific Oncolytic Virus Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 39. Amgen Company Details
Table 40. Amgen Business Overview
Table 41. Amgen Oncolytic Virus Therapy Product
Table 42. Amgen Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 43. Amgen Recent Development
Table 44. Oncolytics Biotech Company Details
Table 45. Oncolytics Biotech Business Overview
Table 46. Oncolytics Biotech Oncolytic Virus Therapy Product
Table 47. Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 48. Oncolytics Biotech Recent Development
Table 49. Viralytics Company Details
Table 50. Viralytics Business Overview
Table 51. Viralytics Oncolytic Virus Therapy Product
Table 52. Viralytics Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 53. Viralytics Recent Development
Table 54. Transgene SA Company Details
Table 55. Transgene SA Business Overview
Table 56. Transgene SA Oncolytic Virus Therapy Product
Table 57. Transgene SA Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 58. Transgene SA Recent Development
Table 59. Oncolys BioPharma Company Details
Table 60. Oncolys BioPharma Business Overview
Table 61. Oncolys BioPharma Oncolytic Virus Therapy Product
Table 62. Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 63. Oncolys BioPharma Recent Development
Table 64. Targovax Company Details
Table 65. Targovax Business Overview
Table 66. Targovax Oncolytic Virus Therapy Product
Table 67. Targovax Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 68. Targovax Recent Development
Table 69. PsiOxus Therapeutics Company Details
Table 70. PsiOxus Therapeutics Business Overview
Table 71. PsiOxus Therapeutics Oncolytic Virus Therapy Product
Table 72. PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 73. PsiOxus Therapeutics Recent Development
Table 74. SillaJen Biotherapeutics Company Details
Table 75. SillaJen Biotherapeutics Business Overview
Table 76. SillaJen Biotherapeutics Oncolytic Virus Therapy Product
Table 77. SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 78. SillaJen Biotherapeutics Recent Development
Table 79. Sorrento Therapeutics Company Details
Table 80. Sorrento Therapeutics Business Overview
Table 81. Sorrento Therapeutics Oncolytic Virus Therapy Product
Table 82. Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 83. Sorrento Therapeutics Recent Development
Table 84. Lokon Pharma Company Details
Table 85. Lokon Pharma Business Overview
Table 86. Lokon Pharma Oncolytic Virus Therapy Product
Table 87. Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 88. Lokon Pharma Recent Development
Table 89. Genelux Corporation Company Details
Table 90. Genelux Corporation Business Overview
Table 91. Genelux Corporation Oncolytic Virus Therapy Product
Table 92. Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 93. Genelux Corporation Recent Development
Table 94. Vyriad Company Details
Table 95. Vyriad Business Overview
Table 96. Vyriad Oncolytic Virus Therapy Product
Table 97. Vyriad Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 98. Vyriad Recent Development
Table 99. TILT Biotherapeutics Company Details
Table 100. TILT Biotherapeutics Business Overview
Table 101. TILT Biotherapeutics Oncolytic Virus Therapy Product
Table 102. TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 103. TILT Biotherapeutics Recent Development
Table 104. Cold Genesys Company Details
Table 105. Cold Genesys Business Overview
Table 106. Cold Genesys Oncolytic Virus Therapy Product
Table 107. Cold Genesys Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 108. Cold Genesys Recent Development
Table 109. Oncolytic Virus Therapy Market Trends
Table 110. Oncolytic Virus Therapy Market Drivers
Table 111. Oncolytic Virus Therapy Market Challenges
Table 112. Oncolytic Virus Therapy Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncolytic Virus Therapy Product Picture
Figure 2. Global Oncolytic Virus Therapy Market Share by Type: 2024 VS 2031
Figure 3. HSV-based Oncolytic Viruses Features
Figure 4. Adenoviruses-based Oncolytic Viruses Features
Figure 5. Vaccinia Virus-based Oncolytic Viruses Features
Figure 6. Vesicular Stomatitis Virus-based Oncolytic Viruses Features
Figure 7. Newcastle Disease Virus-based Oncolytic Viruses Features
Figure 8. Global Oncolytic Virus Therapy Market Share by Application: 2024 VS 2031
Figure 9. Melanoma
Figure 10. Prostate Cancer
Figure 11. Breast Cancer
Figure 12. Ovarian Cancer
Figure 13. Others
Figure 14. Oncolytic Virus Therapy Report Years Considered
Figure 15. Global Oncolytic Virus Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Oncolytic Virus Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Oncolytic Virus Therapy Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Oncolytic Virus Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Europe Oncolytic Virus Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Asia Pacific Oncolytic Virus Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Global Oncolytic Virus Therapy Market Share by Players in 2024
Figure 22. Global Top Oncolytic Virus Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Oncolytic Virus Therapy Revenue in 2024
Figure 24. North America Oncolytic Virus Therapy Market Share by Type (2020-2025)
Figure 25. North America Oncolytic Virus Therapy Market Share by Application (2020-2025)
Figure 26. Europe Oncolytic Virus Therapy Market Share by Type (2020-2025)
Figure 27. Europe Oncolytic Virus Therapy Market Share by Application (2020-2025)
Figure 28. Asia Pacific Oncolytic Virus Therapy Market Share by Type (2020-2025)
Figure 29. Asia Pacific Oncolytic Virus Therapy Market Share by Application (2020-2025)
Figure 30. Amgen Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 31. Oncolytics Biotech Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 32. Viralytics Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 33. Transgene SA Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 34. Oncolys BioPharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 35. Targovax Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 36. PsiOxus Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 37. SillaJen Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 38. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 39. Lokon Pharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 40. Genelux Corporation Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 41. Vyriad Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 42. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 43. Cold Genesys Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Table 1. Global Oncolytic Virus Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Oncolytic Virus Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Oncolytic Virus Therapy Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Oncolytic Virus Therapy Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Oncolytic Virus Therapy Revenue Share by Region (2020-2025)
Table 6. Global Oncolytic Virus Therapy Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Oncolytic Virus Therapy Revenue Share Forecast by Region (2026-2031)
Table 8. Global Oncolytic Virus Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Oncolytic Virus Therapy Revenue Market Share by Type (2020-2025)
Table 10. Global Oncolytic Virus Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Oncolytic Virus Therapy Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Oncolytic Virus Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Oncolytic Virus Therapy Revenue Market Share by Application (2020-2025)
Table 15. Global Oncolytic Virus Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Oncolytic Virus Therapy Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Oncolytic Virus Therapy Application
Table 18. Global Oncolytic Virus Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Oncolytic Virus Therapy Market Share by Players (2020-2025)
Table 20. Global Top Oncolytic Virus Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2024)
Table 21. Ranking of Global Top Oncolytic Virus Therapy Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Oncolytic Virus Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Oncolytic Virus Therapy, Headquarters and Area Served
Table 24. Global Key Players of Oncolytic Virus Therapy, Product and Application
Table 25. Global Key Players of Oncolytic Virus Therapy, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Oncolytic Virus Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Oncolytic Virus Therapy Revenue Market Share by Company (2020-2025)
Table 29. North America Oncolytic Virus Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Oncolytic Virus Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Oncolytic Virus Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Oncolytic Virus Therapy Revenue Market Share by Company (2020-2025)
Table 33. Europe Oncolytic Virus Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Oncolytic Virus Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 35. Asia Pacific Oncolytic Virus Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 36. Asia Pacific Oncolytic Virus Therapy Revenue Market Share by Company (2020-2025)
Table 37. Asia Pacific Oncolytic Virus Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 38. Asia Pacific Oncolytic Virus Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 39. Amgen Company Details
Table 40. Amgen Business Overview
Table 41. Amgen Oncolytic Virus Therapy Product
Table 42. Amgen Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 43. Amgen Recent Development
Table 44. Oncolytics Biotech Company Details
Table 45. Oncolytics Biotech Business Overview
Table 46. Oncolytics Biotech Oncolytic Virus Therapy Product
Table 47. Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 48. Oncolytics Biotech Recent Development
Table 49. Viralytics Company Details
Table 50. Viralytics Business Overview
Table 51. Viralytics Oncolytic Virus Therapy Product
Table 52. Viralytics Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 53. Viralytics Recent Development
Table 54. Transgene SA Company Details
Table 55. Transgene SA Business Overview
Table 56. Transgene SA Oncolytic Virus Therapy Product
Table 57. Transgene SA Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 58. Transgene SA Recent Development
Table 59. Oncolys BioPharma Company Details
Table 60. Oncolys BioPharma Business Overview
Table 61. Oncolys BioPharma Oncolytic Virus Therapy Product
Table 62. Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 63. Oncolys BioPharma Recent Development
Table 64. Targovax Company Details
Table 65. Targovax Business Overview
Table 66. Targovax Oncolytic Virus Therapy Product
Table 67. Targovax Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 68. Targovax Recent Development
Table 69. PsiOxus Therapeutics Company Details
Table 70. PsiOxus Therapeutics Business Overview
Table 71. PsiOxus Therapeutics Oncolytic Virus Therapy Product
Table 72. PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 73. PsiOxus Therapeutics Recent Development
Table 74. SillaJen Biotherapeutics Company Details
Table 75. SillaJen Biotherapeutics Business Overview
Table 76. SillaJen Biotherapeutics Oncolytic Virus Therapy Product
Table 77. SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 78. SillaJen Biotherapeutics Recent Development
Table 79. Sorrento Therapeutics Company Details
Table 80. Sorrento Therapeutics Business Overview
Table 81. Sorrento Therapeutics Oncolytic Virus Therapy Product
Table 82. Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 83. Sorrento Therapeutics Recent Development
Table 84. Lokon Pharma Company Details
Table 85. Lokon Pharma Business Overview
Table 86. Lokon Pharma Oncolytic Virus Therapy Product
Table 87. Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 88. Lokon Pharma Recent Development
Table 89. Genelux Corporation Company Details
Table 90. Genelux Corporation Business Overview
Table 91. Genelux Corporation Oncolytic Virus Therapy Product
Table 92. Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 93. Genelux Corporation Recent Development
Table 94. Vyriad Company Details
Table 95. Vyriad Business Overview
Table 96. Vyriad Oncolytic Virus Therapy Product
Table 97. Vyriad Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 98. Vyriad Recent Development
Table 99. TILT Biotherapeutics Company Details
Table 100. TILT Biotherapeutics Business Overview
Table 101. TILT Biotherapeutics Oncolytic Virus Therapy Product
Table 102. TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 103. TILT Biotherapeutics Recent Development
Table 104. Cold Genesys Company Details
Table 105. Cold Genesys Business Overview
Table 106. Cold Genesys Oncolytic Virus Therapy Product
Table 107. Cold Genesys Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 108. Cold Genesys Recent Development
Table 109. Oncolytic Virus Therapy Market Trends
Table 110. Oncolytic Virus Therapy Market Drivers
Table 111. Oncolytic Virus Therapy Market Challenges
Table 112. Oncolytic Virus Therapy Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncolytic Virus Therapy Product Picture
Figure 2. Global Oncolytic Virus Therapy Market Share by Type: 2024 VS 2031
Figure 3. HSV-based Oncolytic Viruses Features
Figure 4. Adenoviruses-based Oncolytic Viruses Features
Figure 5. Vaccinia Virus-based Oncolytic Viruses Features
Figure 6. Vesicular Stomatitis Virus-based Oncolytic Viruses Features
Figure 7. Newcastle Disease Virus-based Oncolytic Viruses Features
Figure 8. Global Oncolytic Virus Therapy Market Share by Application: 2024 VS 2031
Figure 9. Melanoma
Figure 10. Prostate Cancer
Figure 11. Breast Cancer
Figure 12. Ovarian Cancer
Figure 13. Others
Figure 14. Oncolytic Virus Therapy Report Years Considered
Figure 15. Global Oncolytic Virus Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Oncolytic Virus Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Oncolytic Virus Therapy Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Oncolytic Virus Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Europe Oncolytic Virus Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Asia Pacific Oncolytic Virus Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Global Oncolytic Virus Therapy Market Share by Players in 2024
Figure 22. Global Top Oncolytic Virus Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Oncolytic Virus Therapy Revenue in 2024
Figure 24. North America Oncolytic Virus Therapy Market Share by Type (2020-2025)
Figure 25. North America Oncolytic Virus Therapy Market Share by Application (2020-2025)
Figure 26. Europe Oncolytic Virus Therapy Market Share by Type (2020-2025)
Figure 27. Europe Oncolytic Virus Therapy Market Share by Application (2020-2025)
Figure 28. Asia Pacific Oncolytic Virus Therapy Market Share by Type (2020-2025)
Figure 29. Asia Pacific Oncolytic Virus Therapy Market Share by Application (2020-2025)
Figure 30. Amgen Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 31. Oncolytics Biotech Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 32. Viralytics Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 33. Transgene SA Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 34. Oncolys BioPharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 35. Targovax Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 36. PsiOxus Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 37. SillaJen Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 38. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 39. Lokon Pharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 40. Genelux Corporation Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 41. Vyriad Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 42. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 43. Cold Genesys Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232